Barriers, Solutions, and Opportunities for Adapting Critical Care Clinical Trials in the COVID-19 Pandemic

被引:0
|
作者
Cook, Deborah [1 ,2 ]
Taneja, Shipra [2 ]
Krewulak, Karla [3 ]
Zytaruk, Nicole [2 ]
Menon, Kusum [4 ]
Fowler, Rob [5 ]
Lamontagne, Francois [6 ]
Kho, Michelle E. [7 ]
Rochwerg, Bram [1 ,2 ]
Masse, Marie-Helene [8 ]
Lauzier, Francois [9 ,10 ]
O'Hearn, Katie [11 ]
Adhikari, Neill K. J. [5 ]
Burns, Karen E. A. [5 ,12 ]
Bosma, Karen J. [13 ]
English, Shane [14 ,15 ]
Mcnally, Dayre [4 ]
Turgeon, Alexis F. [9 ,10 ]
Brochard, Laurent [5 ,12 ]
Parker, Melissa [16 ,17 ]
Clayton, Lucy [10 ]
Rishu, Asgar [5 ]
Tuttle, Angie [18 ]
Daneman, Nick [19 ]
Fergusson, Dean [20 ]
Mcintyre, Lauralyn [21 ]
Kelly, Laurel [22 ]
Orr, Sherrie [23 ]
Austin, Peggy [1 ,2 ]
Mulligan, Sorcha [22 ]
Fiest, Kirsten [3 ]
机构
[1] McMaster Univ, Dept Med, 1200 Main St,Room 2C11, Hamilton, ON L8N 3Z5, Canada
[2] McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada
[3] Univ Calgary, Dept Crit Care, Calgary, AB, Canada
[4] Univ Ottawa, Dept Pediat, Ottawa, ON, Canada
[5] Univ Toronto, Interdept Div Crit Care, Toronto, ON, Canada
[6] Univ Sherbrooke, Dept Crit Care, Sherbrooke, PQ, Canada
[7] McMaster Univ, Sch Rehabil Sci, Hamilton, ON, Canada
[8] Ctr Hosp Univ Sherbrooke, Ctr Rech, Sherbrooke, PQ, Canada
[9] Univ Laval, Dept Anesthesiol & Crit Care Med, Div Crit Care Med, Quebec City, PQ, Canada
[10] Univ Laval, CHU Quebec, Res Ctr, Quebec City, PQ, Canada
[11] Childrens Hosp Eastern Ontario, Res Inst, Ottawa, ON, Canada
[12] Unity Hlth Toronto, Li Ka Shing Knowledge Inst, Keenan Res Ctr, Toronto, ON, Canada
[13] Univ Western Ontario, Dept Med, Schulich Sch Med & Dent, Div Crit Care Med, London, ON, Canada
[14] Univ Ottawa, Dept Med Crit Care, Ottawa, ON, Canada
[15] Ottawa Hosp Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada
[16] McMaster Univ, Dept Pediat, Hamilton, ON, Canada
[17] McMaster Univ, Dept Emergency Med, Hamilton, ON, Canada
[18] Ottawa Hosp Res Inst, Ottawa, ON, Canada
[19] Univ Toronto, Div Infect Dis, Dept Med, Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada
[20] Univ Ottawa, Ottawa Hosp Res Inst, Ottawa, ON, Canada
[21] Univ Ottawa, Dept Crit Care Med, Ottawa, ON, Canada
[22] St Josephs Healthcare, Hamilton, ON, Canada
[23] McMaster Univ, Dept Pediat, Hamilton, ON, Canada
关键词
QUALITATIVE RESEARCH; PROTOCOL;
D O I
10.1001/jamanetworkopen.2024.20458
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
IMPORTANCE The COVID-19 pandemic created unprecedented challenges for clinical trials worldwide, threatening premature closure and trial integrity. Every phase of research operations was affected, often requiring modifications to protocol design and implementation. OBJECTIVES To identify the barriers, solutions, and opportunities associated with continuing critical care trials that were interrupted during the pandemic, and to generate suggestions for future trials. DESIGN, SETTING, AND PARTICIPANTS This mixed-methods study performed an explanatory sequential analysis involving a self-administered electronic survey and focus groups of principal investigators (PIs) and project coordinators (PCs) conducting adult and pediatric individual-patient randomized trials of the Canadian Critical Care Trials Group during the COVID-19 pandemic. Eligible trials were actively enrolling patients on March 11, 2020. Data were analyzed between September 2023 and January 2024. MAIN OUTCOMES AND MEASURES Importance ratings of barriers to trial conduct and completion, solutions employed, opportunities arising, and suggested strategies for future trials. Quantitative data examining barriers were analyzed using descriptive statistics. Data addressing solutions, opportunities, and suggestions were analyzed by qualitative content analysis. Integration involved triangulation of data sources and perspectives about 13 trials, synthesized by an interprofessional team incorporating reflexivity and member-checking. RESULTS A total of 13 trials run by 29 PIs and PCs (100% participation rate) were included. The highest-rated barriers (on a 5-point scale) to ongoing conduct during the pandemic were decisions to pause all clinical research (mean [SD] score, 4.7 [0.8]), focus on COVID-19 studies (mean [SD] score, 4.6 [0.8]), and restricted family presence in hospitals (mean [SD] score, 4.1 [0.8]). Suggestions to enable trial progress and completion included providing scientific leadership, implementing technology for communication and data management, facilitating the informed consent process, adapting the protocol as necessary, fostering site engagement, initiating new sites, streamlining ethics and contract review, and designing nested studies. The pandemic necessitated new funding opportunities to sustain trial enrollment. It increased public awareness of critical illness and the importance of randomized trial evidence. CONCLUSIONS AND RELEVANCE While underscoring the vital role of research in society and drawing the scientific community together with a common purpose, the pandemic signaled the need for innovation to ensure the rigor and completion of ongoing trials. Lessons learned to optimize research procedures will help to ensure a vibrant clinical trials enterprise in the future.
引用
收藏
页数:15
相关论文
共 50 条
  • [41] Kidney Stone Care and the COVID-19 Pandemic: Challenges and Opportunities
    Hiller, Spencer C.
    Dauw, Casey A.
    Ghani, Khurshid R.
    JOURNAL OF UROLOGY, 2020, 204 (06): : 1122 - 1124
  • [42] Patient care and clinical trials in gynecological oncology: Implications of the COVID-19 pandemic.
    Nasser, Sara
    Fotopoulou, Christina
    Guktekin, Murat
    Dimitrova, Desislava
    Morice, Philippe
    Sehouli, Jalid
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [43] Adapting clinical psychological practices for pain during the COVID-19 pandemic
    Masselin-Dubois, A.
    Enert-Barbero, N.
    Gazagne, A.
    PRATIQUES PSYCHOLOGIQUES, 2022, 28 (02) : 59 - 79
  • [44] Adapting Tobacco Treatment to Telemedicine During the COVID-19 Pandemic: Benefits, Barriers, and Results
    Deepak, J.
    Chan, J.
    Melamed, J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [45] Veterinary oncologists adapting to COVID-19 pandemic
    Marconato, Laura
    Finotello, Riccardo
    VETERINARY AND COMPARATIVE ONCOLOGY, 2020, 18 (03) : 257 - 257
  • [46] Critical but stable-critical care communication in the COVID-19 pandemic**
    Tan, Mark Z. Y.
    INTENSIVE CARE MEDICINE, 2022, 48 (08) : 1127 - 1129
  • [47] Allocation of Opportunities to Participate in Clinical Trials during the Covid-19 Pandemic and Other Public Health Emergencies
    Spector-Bagdady, Kayte
    Lynch, Holly Fernandez
    Bierer, Barbara E.
    Gelinas, Luke
    Hull, Sara Chandros
    Magnus, David
    Meyer, Michelle N.
    Sharp, Richard R.
    Sugarman, Jeremy
    Wilfond, Benjamin S.
    Yearby, Ruqaiijah
    Mohapatra, Seema
    HASTINGS CENTER REPORT, 2022, 52 (01) : 51 - 58
  • [48] The COVID-19 pandemic and depression among medical students: Barriers and solutions
    Khuram, Hassan
    Maddox, Parker Alan
    Hirani, Rahim
    Issani, Ali
    PREVENTIVE MEDICINE, 2023, 171
  • [49] Models for Evidence Generation During the COVID-19 Pandemic: New Opportunities for Clinical Trials in Cardiovascular Medicine
    Lawler, Patrick R.
    CIRCULATION, 2023, 147 (03) : 187 - 189
  • [50] The inverse care law in critical care during the COVID-19 pandemic
    Hainey, Kirsten J.
    Katikireddi, Srinivasa Vittal
    LANCET REGIONAL HEALTH-EUROPE, 2021, 1